April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
Colorectal tumor biomarker may predict immunotherapy effectiveness
May 2, 2019 | Zen Vuong
The takeaway of foundational research by a City of Hope physician-scientist and his colleagues is that patients with metastatic colorectal cancer and a high tumor mutation score should consider immunotherapy as initial treatment.
Combined immunotherapy could tackle advanced cancers
April 15, 2019 | Zen Vuong
City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.
Australian patient travels 9,000 miles for a cure
March 7, 2019 | Michael Easterling
Australian lobster fisherman David Thompson traveled 9,000 miles for treatment at City of Hope after being diagnosed with Stage 4 oropharyngeal cancer. Given just six weeks to live, he is thriving more than a year after participating in an immunotherapy clinical trial.
New Immunotherapy for Colon Cancer Answers a Patient's Prayer
December 24, 2018 | Maxine Nunes
After a CAT scan found a suspicious spot, a colonoscopy showed that Quiana Godinez had colon cancer. Godinez was put on the breakthrough immunotherapy drug Keytruda (pembrolizumab), which had just received FDA approval for certain types of cancers, including hers.
Wife, mother of two in remission thanks to experimental CAR T cell therapy
December 20, 2018 | Leti Marquez & Zen Vuong
Meet float rider Cheryl Wiers, a wife and mother of two who battled cancer twice only to have it return. She eventually found prolonged remission thanks to a CAR T Cell therapy offered at City of Hope.